2020
DOI: 10.1080/00207454.2020.1807979
|View full text |Cite
|
Sign up to set email alerts
|

S100B protein: general characteristics and pathophysiological implications in the Central Nervous System

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
7
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(7 citation statements)
references
References 72 publications
0
7
0
Order By: Relevance
“…The above findings suggest that the four hub genes were possibly related to human disorder genesis and progression, like OP. Chromosomal rearrangement and expression changes of S100B gene have been verified to be related to several nervous system diseases, neoplastic diseases, endocrine diseases like Alzheimer’s disease (AD), Down’s syndrome, epilepsy, amyotrophic lateralizing sclerosis, tumor and type 1 diabetes ( 38 , 39 ). In addition, FGF13 has extensive activities in promoting mitosis and cell survival, which participates in numerous biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion ( 40 ).…”
Section: Discussionmentioning
confidence: 99%
“…The above findings suggest that the four hub genes were possibly related to human disorder genesis and progression, like OP. Chromosomal rearrangement and expression changes of S100B gene have been verified to be related to several nervous system diseases, neoplastic diseases, endocrine diseases like Alzheimer’s disease (AD), Down’s syndrome, epilepsy, amyotrophic lateralizing sclerosis, tumor and type 1 diabetes ( 38 , 39 ). In addition, FGF13 has extensive activities in promoting mitosis and cell survival, which participates in numerous biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion ( 40 ).…”
Section: Discussionmentioning
confidence: 99%
“…To obtain quantitative insight into the distribution of clinically employed CSF biomarkers, we determined the ventricular versus lumbar levels of selected biomarkers with an ELISA-based approach. Of the employed biomarkers, only one (a biomarker of general neurodegeneration; S100B [38][39][40][41]) was detected in both the ELISA-based approach and the mass spectrometry-based analysis, and to verify the comparability between the approaches, we compared S100B between the methods (Fig. 3A).…”
Section: Clinical Biomarkers Distribute Differentially In the Csf Com...mentioning
confidence: 99%
“…Calcium-binding protein Primarily produced by astrocytes and mainly expressed in the cytoplasm of these cells, but oligodendrocytes also express S100B. This protein is involved in calcium homeostasis, and as glial cells are sensitive to CNS disturbances, S100B is usually regarded as an indirect biomarker of neural injury [103,[204][205][206][207] ↑ in a model of stroke-prone spontaneously hypertensive rats [204]; ↓ in a model of diabetic ketoacidosis brain injury [205]; ↑ in an in vitro model of MS [206] Cytokines…”
Section: S100bmentioning
confidence: 99%